ReviewInternational dental journal2026
FDA-Approved AI Solutions in Dental Imaging: A Narrative Review of Applications, Evidence, and Outlook.
Review in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- A narrative review of artificial intelligence in dental imaging: from dataset design to clinical translation.Oral radiology · 2026Review
- Beyond Regulatory Approval: Lifecycle Assurance for Clinical Artificial Intelligence.Journal of medical systems · 2026Article
- Review
- Clinical Reliability of AI-Based Cephalometric Analysis Using WebCeph: A Comparative Agreement Study.Journal of clinical medicine · 2026Article
- Multi-class anatomical landmark detection in periapical radiographs with deep learning.Odontology · 2026Article
- Artificial intelligence for teaching, training, and assessment in dental education: a domain-based scoping review.Frontiers in medicine · 2026Review
- Artificial intelligence for dental caries diagnosis: translating algorithms to clinical practice.Frontiers in medicine · 2026Review
- A six-level clinical autonomy framework for artificial intelligence in dentistry.Frontiers in oral health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimsArtificial intelligence (AI) has rapidly transformed dental imaging by enabling automated detection, diagnosis, and analysis of various dental conditions. However, a comprehensive synthesis of United States Food and Drug Administration (FDA)-cleared, clinically validated AI solutions in dental imaging remains limited. This review aims to catalog all standalone, cloud-based dental AI platforms with FDA clearance, highlighting their clinical applications, performance outcomes, and supporting evidence to guide evidence-based integration.
methodsA two-phase systematic search was conducted. In the first phase, searches of U.S. FDA regulatory databases (510[k], De Novo, and PMA) were performed through July 2025 to identify standalone, cloud-based dental AI imaging devices cleared or authorized for autonomous or semi-autonomous analysis. In the second phase, PubMed, Web of Science, and Google Scholar were systematically searched to retrieve studies assessing the performance or clinical utility of the identified platforms. Two independent reviewers performed data screening and extraction, with discrepancies resolved by a third reviewer.
resultsThirteen companies were identified as offering twenty-nine FDA-cleared AI products for dental imaging. These solutions addressed diverse clinical tasks, including caries detection, periodontal disease assessment, cephalometric analysis, multi-pathology diagnostics, automated dental charting, and three-dimensional segmentation. Performance outcomes reported by the FDA demonstrated high accuracy, sensitivity, and specificity across most platforms, particularly for caries detection, periodontal disease measurement, and cephalometric analysis. Among these, Relu Creator and WebCeph were supported by the highest number of peer-reviewed publications, whereas several newer platforms lacked independent clinical validation.
conclusionStandalone, FDA-cleared AI platforms represent a paradigm shift in dental imaging, providing clinically validated tools for diagnosis, treatment planning, and patient monitoring. By systematically cataloging these solutions, this review delivers an evidence-based reference for clinicians and researchers, supporting informed adoption and identifying areas for future investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.